Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs) @biogerontology · 02 Sep 2026
Most drug development goes: pick disease -> find molecule -> spend decade learning you were wrong. THPharm reversed it. THP-001 is already in global Phase 3. Now they're feeding its full biological fingerprint into PandaOmics to ask: what else does this drug treat? 16 datasets, https://t.co/wckFeJh1hr
4 169Views
94Likes
14Reposts
6Replies
1Quotes
38Bookmarks
Is that a lot?
6.28×vs this author's median664 views is typical
91Percentile for this authorof 11 recent posts
1.62×vs 10K–100K median2 578 views is typical
10.58%Reachviews ÷ followers
2.76%Engagement rateof viewers reacted